Gosset Marie, Gal Jocelyn, Schiappa Renaud, Dejode Magali, Fouché Yves, Alazet Fanny, Roux Emilie, Delpech Yann, Barranger Emmanuel
Université Côte d'Azur, centre Antoine-Lacassagne, département de chirurgie sénologique et onco-gynécologique, 33, avenue de Valombrose, 06189 Nice cedex, France.
Université Côte d'Azur, centre Antoine-Lacassagne, département d'épidémiologie, de biostatistiques et des données de santé (DEBDS), 33, avenue de Valombrose, 06189 Nice cedex, France.
Bull Cancer. 2021 Jan;108(1):3-11. doi: 10.1016/j.bulcan.2020.10.013. Epub 2020 Nov 26.
During the COVID-19 pandemic, the containment measures and the recommendations of several societies in oncology may have impacted the request for initial care for cancers.
In this monocentric retrospective study, the number and the characteristics of patients received for a first consultation for a breast or gynecologic tumor were compared between the containment period and a control period. The times from diagnosis to treatment and the type of initial care were compared too.
During the outbreak, 91 patients were seen for a new request, versus 159 during the control period, a decrease of 43.5 %. Patients were older (62.9 versus 60.9 years old) but this difference was not significant. Tumor stage was not modified. Concerning senology, the time from the biopsy to the first consultation was 5.5 days longer during the outbreak (difference statistically insignificant). Among the 51 patients requiring a surgical treatment during the outbreak, 16 (31.48 %) were postponed after the end of the containment measures. After all, the average time from the consultation to the treatment was not modified. No modification of type of treatment was observed.
At the height of the pandemic, benefits and risks of the cancer treatment had to be daily balanced against the risk of exposition to the COVID-19. The evaluation of practices for cancer care is essential to understand the real impact of COVID-19 outbreak on global cancer management, so as to get prepared to further crises.
在新冠疫情期间，多项肿瘤学领域的防控措施及学会建议可能影响了癌症初诊需求。
在这项单中心回顾性研究中，对比了隔离期与对照期因乳腺或妇科肿瘤首次就诊的患者数量及特征。还比较了从诊断到治疗的时间以及初诊类型。
疫情期间，新就诊患者91例，对照期为159例，减少了43.5%。患者年龄更大（62.9岁对60.9岁），但差异不显著。肿瘤分期未改变。在乳腺病学方面，疫情期间从活检到首次就诊的时间长5.5天（差异无统计学意义）。疫情期间需要手术治疗的51例患者中，16例（31.48%）在隔离措施结束后被推迟手术。总体而言，从就诊到治疗的平均时间未改变。未观察到治疗类型的改变。
在疫情高峰期，癌症治疗的利弊必须每天与感染新冠病毒的风险相权衡。评估癌症护理实践对于理解新冠疫情对全球癌症管理的实际影响至关重要，以便为未来的危机做好准备。
